LifeVantage
Corporation (OTCBB:LFVN),the maker of Protandim®
- a dietary supplement clinically shown to induce the body's own
antioxidant defenses - today announced that some of the most sought
after and highest producing independent distributors in the network
marketing industry have joined LifeVantage as independent distributors.
These distributors, including Jason Domingo, Tyler Daniels and Marcell
Niederhauser, are well-known in the industry for being among the primary
drivers of record-setting revenue growth at previous companies.
David Brown, LifeVantage President and CEO, said, "We are
extraordinarily fortunate to join forces with Jason, Tyler, Marcell and
their team. Their one year revenue growth record is legendary in the
industry and we believe could significantly impact LifeVantage's rapid
expansion into the network marketing sales channel. Every network
marketing company in the industry would love to have this team and the
fact that they chose to join us is a testament to the strength of the
science behind Protandim® and that they share our belief that
this can become a powerful, global brand."
Jason Domingo said, "It is an exciting time to be on the ground floor of
the LifeVantage home-based business opportunity. Our distributor team is
proud of our reputation and track record in the network marketing
industry and therefore was extremely selective when reviewing potential
network marketing homes. We selected LifeVantage for its unique ability
to affect lives globally. In our opinion, Protandim®, backed
by peer reviewed studies, is in a product category all by itself and
clearly delineates the LifeVantage opportunity from its network
marketing counterparts."
In addition, Kirby Zenger, a highly regarded executive who co-founded
one of the fastest growing network marketing companies, is joining the
LifeVantage team, as well as other industry management and
administrative professionals. Said Brown, "Given the demonstrated
ability of this team of independent distributors to drive rapid growth,
we want to be totally prepared to meet all of the needs of our
distributors and customers. This dramatically expands the company's
bandwidth in the areas of sales, marketing, branding, operations,
product development and international expansion."
About
Protandim®
Protandim® is a groundbreaking, clinically proven supplement
that provides a substantial benefit to help with the challenge of
healthy aging. This patented antioxidant therapy is more powerful than
conventional foods such as red wine, oranges, blueberries or other
popular antioxidant supplements. Protandim works by increasing the
body's natural antioxidant protection at the cellular level, triggering
cells to produce naturally occurring protective antioxidant enzymes such
as super oxide dismutase (SOD), catalase, and glutathione.
A peer-reviewed human study showed that after Protandim® was
taken for 30 consecutive days, the accumulation of lipid peroxidation
products (a biochemical marker of aging) was decreased by an average of
40%. The study also reported that this important marker of aging was
decreased after taking Protandim® to the level of a typical
20 year old. Protandim® is currently the subject of over 20
scientific studies at leading universities and research institutes. For
more information, please visitwww.LifeVantage.comor contact Jan Strode at (619) 890-4040.
About
LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB:LFVN), science
based, natural products company, dedicated to helping people reach their
health and wellness goals through science-based solutions to oxidative
stress. Founded in 2003 and based in Colorado, LifeVantage develops
nutraceutical products, including Protandim®,
that leverage the company's expertise and that are intended to deliver
significant health benefits to consumers. For more information, visit www.lifevantage.com
or contact Jan Strode at (619) 890-4040.
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995.The Company uses the words "anticipate," "believe,"
"could," "should," "estimate," "expect," "intend," "may," "predict,"
"project," "plan," "target" and similar terms and phrases, including
references to assumptions, to identify forward-looking statements.These
forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties that may cause the
Company's actual results or outcomes to be materially different from
those anticipated and discussed herein.These risks and
uncertainties include, among others, the risk that government regulators
and regulations could adversely affect our business; future laws or
regulations may hinder or prohibit the production or sale of our
existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company's ability to protect our
intellectual property rights and the value of our product.These
and other risk factors are discussed in greater detail in the Company's
Annual Report on Form 10-KSB under the caption "Risk Factors", and in
other documents filed the Company from time to time with the Securities
and Exchange Commission.The Company cautions investors not to
place undue reliance on the forward-looking statements contained in this
document.All forward-looking statements are based on information
currently available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of this
document, except as required by law.
*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 for interviews,
photography, and other requests.
LifeVantage Corporation
Jan Strode, 619-890-4040
or
Jean
Golden, 612-385-2324